444 McAbee, K.P., L.L. Ludwig, P.J. Bergman, et al. 2005. Feline cutaneous hemangiosarcoma: A retrospective study of 18 cases (1998–2003). J Am Anim Hosp Assoc 41:110–116.
445 McCaw, D.L., M.A. Miller, P.J. Bergman, et al. 1997. Vincristine therapy for mast cell tumors in dogs. J Vet Intern Med 11:375–378.
446 McChesney, A.E., L.C. Stephens, J. Lebel, et al. 1980. Infiltrative lipoma in dogs. Vet Pathol 17:316–322.
447 McEntee, M.C. and R.L. Page. 2001. Feline vaccine‐associated sarcomas. J Vet Intern Med 15:176–182.
448 McEntee, M.C., R.L. Page, G.N. Mauldin, et al. 2000. Results of irradiation of infiltrative lipoma in 13 dogs. Vet Radiol Ultrasound 41:554–556.
449 McEntee, M.C., R.L. Page, and C.A. Novotney. 1993. Palliative radiotherapy for canine appendicular osteosarcoma. Vet Radiol Ultrasound 34:367–370.
450 McEntee, M.C., V.F. Samii, P. Walsh, et al. 2004. Postoperative assessment of surgical clip position in 16 dogs with cancer: a pilot study. J Am Anim Hosp Assoc 40(4):300–308.
451 McEntee, M.C., M. Steffey, and N.L. Dykes. 2008. Use of surgical hemoclips in radiation treatment planning. Vet Radiol Ultrasound 49:395–399.
452 McKnight, J.A., G.N. Mauldin, M.C. McEntee, et al. 2000. Radiation treatment for incompletely resected soft‐tissue sarcomas in dogs. J Am Vet Med Assoc 217:205–210.
453 McLean, J.L. and R.G. Lobetti. 2015. Use of the melanoma vaccine in 38 dogs: The South African experience. J S Afr Vet Assoc 86:1246.
454 McMahon, M., T. Mathie, N. Stingle, et al. 2011. Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma. J Vet Intern Med 25:511–517.
455 McMillan, S.K., P. Boria, G.E. Moore, et al. 2011. Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder. J Am Vet Med Assoc 239:1084–1089.
456 McMillan, S.K., D.W. Knapp, J.A. Ramos‐Vara, et al. 2012. Outcome of urethral stent placement for management of urethral obstruction secondary to transitional cell carcinoma in dogs: 19 cases (2007–2010). J Am Vet Med Assoc 241:1627–1632.
457 McNeill, C.J., K.U. Sorenmo, F.S. Shofer, et al. 2009. Evaluation of adjuvant doxorubicin‐based chemotherapy for the treatment of feline mammary carcinoma. J Vet Intern Med 23:123–129.
458 McQuown, B., M.A. Keyerleber, K. Rosen, et al. 2017. Treatment of advanced canine anal sac adenocarcinoma with hypofractionated radiation therapy: 77 cases (1999–2013). Vet Comp Oncol 15:840–851.
459 McSporran, K.D. 2009. Histologic grade predicts recurrence for marginally excised canine subcutaneous soft tissue sarcomas. Vet Pathol 46:928–933.
460 Meier, V., C. Geigy, N. Grosse, et al. 2013. Use of epothilone B (patupilone) in refractory lymphoma and advanced solid tumors in dogs. J Vet Intern Med 27:120–125.
461 Meis, J.M., J.J. Butler, B.M. Osborne, et al. 1987. Solitary plasmacytomas of bone and extramedullary plasmacytomas. A clinicopathologic and immunohistochemical study. Cancer 59:1475–1485.
462 Melendez, L.M., R.M. Yamka, and P.A. Burris. 2011a. Titration of dietary iodine for maintaining serum thyroxine concentrations in hyperthyroid cats [abstract]. J Vet Intern Med 26:683.
463 Melendez, L.M., R.M. Yamka, and S.D. Forrester. 2011b. Titration of dietary iodine for reducing serum thyroxine concentrations in newly diagnosed hyperthyroid cats (abstract). J Vet Intern Med 25:683.
464 Mellanby, R.J., R.K. Stevenson, M.E. Herrtage, et al. 2002. Long‐term outcome of 56 dogs with nasal tumours treated with four doses of radiation at intervals of seven days. Vet Rec 151:253–257.
465 Michels, G.M., D.W. Knapp, D.B. Denicola, et al. 2002. Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor‐free versus nontumor‐free margins: A retrospective study of 31 cases. J Am Anim Hosp Assoc 38:458–466.
466 Miller, M.A., J.A. Ramos, and J.M. Kreeger. 1992. Cutaneous vascular neoplasia in 15 cats: Clinical, morphologic, and immunohistochemical studies. Vet Pathol 29:329–336.
467 Miller, R.L., S. Van Lelyveld, J. Warland, et al. 2016. A retrospective review of treatment and response of high‐risk mast cell tumours in dogs. Vet Comp Oncol 14(4):361–370.
468 Milner, R.J., C.D. Channell, J.K. Levy, et al. 2006. Survival times for cats with hyperthyroidism treated with iodine 131, methimazole, or both: 167 cases (1996–2003). J Am Vet Med Assoc 228:559–563.
469 Milner, R.J., I. Dormehl, W.K. Louw, et al. 1998. Targeted radiotherapy with Sm‐153‐EDTMP in nine cases of canine primary bone tumors. J S Afr Vet Assoc 69:12–17.
470 Milovancev, M., D.M. Wilson, E. Monnet, et al. 2014. Partial resection of the hyoid apparatus during surgical treatment of ectopic thyroid carcinomas in dogs: 5 cases (2011–2013). J Am Vet Med Assoc 244:1319–1324.
471 Moldovanu, G., M. Friedman, and D.G. Miller. 1966. Treatment of canine malignant lymphoma with surgery and chemotherapy. J Am Vet Med Assoc 148:153–156.
472 Molnar, T. and P. Vajdovich. 2012. Clinical factors determining the efficacy of urinary bladder tumour treatments in dogs: Surgery, chemotherapy or both? Acta Vet Hung 60:55–68.
473 Monteiro, B., S. Boston, and G. Monteith. 2011. Factors influencing complete tumor excision of mast cell tumors and soft tissue sarcomas: A retrospective study in 100 dogs. Can Vet J 52:1209–1214.
474 Montgomery, R.D. and G.H. Hankes. 1987. Ureterocolonic anastomosis in a dog with transitional cell carcinoma of the urinary bladder. J Am Vet Med Assoc 190:1427–1429.
475 Montinaro, V., S.E. Boston, P. Buracco, et al. 2013. Clinical outcome of 42 dogs with scapular tumors treated by scapulectomy: A Veterinary Society of Surgical Oncology (VSSO) retrospective study (1995–2010). Vet Surg 42:943–950.
476 Mooney, C.T. 2001. Feline hyperthyroidism. Diagnostics and therapeutics. Vet Clin North Am Small Anim Pract 31:963–983, viii.
477 Moore, A.S. 1993. Recent advances in chemotherapy for nonlymphoid malignant neoplasms. Compend Contin Educ Pract Vet 15:1039–1050.
478 Moore, A.S., S.M. Cotter, W.M. Rand, et al. 2001. Evaluation of a discontinuous treatment protocol (Velcap‐S) for canine lymphoma. J Vet Intern Med 15:348–354.
479 Moore, A.S., C. Kirk, and A. Cardona. 1991a. Intracavitary cisplatin chemotherapy experience with six dogs. J Vet Intern Med 5:227–231.
480 Moore, A.S., C. Kirk, and A. Cardona. 1991b. Intracavitary cisplatin chemotherapy experience with six dogs. J Vet Intern Med 5:277–231.
481 Moore, A.S., R.W. Nelson, C.J. Henry, et al. 2002. Streptozocin for treatment of pancreatic islet cell tumors in dogs: 17 cases (1989–1999). J Am Vet Med Assoc 221:811–818.
482 Moore, A.S., G.H. Theilen, A.D. Newell, et al. 1991c. Preclinical study of sequential tumor necrosis factor and interleukin 2 in the treatment of spontaneous canine neoplasms. Cancer Res 51:233–238.
483 Morello, E., P. Buracco, M. Martano, et al. 2001. Bone allografts and adjuvant cisplatin for the treatment of canine appendicular osteosarcoma in 18 dogs. J Small Anim Pract 42:61–66.
484 Morello, E., M. Martano, C. Squassino, et al. 2008. Transanal pull‐through rectal amputation for treatment of colorectal carcinoma in 11 dogs. Vet Surg 37:420–426.
485 Morello, E., E. Vasconi, M. Martano, et al. 2003. Pasteurized tumoral autograft and adjuvant chemotherapy for the treatment of canine distal radial osteosarcoma: 13 cases. Vet Surg 32:539–544.
486 Morris, J.S., J.M. Dobson, D.E. Bostock, et al. 1998. Effect of ovariohysterectomy in bitches with mammary neoplasms. Vet Rec 142:656–658.
487 Morrison‐Collister, K.E., K.M. Rassnick, N.C. Northrup, et al. 2003. A combination chemotherapy protocol with MOPP and CCNU